United States: Takeda licenses small molecule developed by researchers at UHN's Krembil Brain Institute, targeting tau protein implicated in Alzheimer's disease.
In: TendersInfo News, 2023-04-19
Zeitungsartikel
Zugriff:
Titel: |
United States: Takeda licenses small molecule developed by researchers at UHN's Krembil Brain Institute, targeting tau protein implicated in Alzheimer's disease.
|
---|---|
Zeitschrift: | TendersInfo News, 2023-04-19 |
Veröffentlichung: | 2023 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|